Werewolf Therapeutics, Inc.
HOWL- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001785530
In the last 90 days, Werewolf Therapeutics, Inc. insiders filed 0 open-market purchases and 1 sale; 45 institutions reported holding it in 13F filings for Q2 2026, worth $3.91M in total; no superinvestor holds it.
Q2 2024 vs. Q1 2024
How the institutions holding Werewolf Therapeutics, Inc. changed between Q1 2024 and Q2 2024.
All holders in Q2 2024All holders in Q1 2024
| Measure | Q1 2024 | Q2 2024 | Change |
|---|---|---|---|
| Holders | 61 | 71 | +10 |
| Shares | 32.3M | 32.5M | +217.5K (+0.7%) |
| Value | $209.0M | $79.2M | −$129.7M (−62.1%) |
New holders (22)
Institutions that held Werewolf Therapeutics, Inc. at the end of Q2 2024 but not at the end of Q1 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Point72 Asset Management, L.P. | 319,477 | $779.5K | 0.00% |
| BIT Capital GmbH | 233,370 | $569.4K | 0.05% |
| Walleye Capital LLC | 98,440 | $240.2K | 0.00% |
| Charles Schwab Investment Management Inc | 78,842 | $192.4K | 0.00% |
| Bank of New York Mellon Corp | 67,644 | $165.1K | 0.00% |
| Murchinson Ltd. | 62,500 | $152.5K | 0.03% |
| Nuveen Asset Management, LLC | 52,048 | $127.0K | 0.00% |
| New York State Common Retirement Fund | 39,900 | $97.4K | 0.00% |
| Alpine Global Management, LLC | 37,551 | $91.6K | 0.02% |
| Boothbay Fund Management, LLC | 37,500 | $91.5K | 0.00% |
| Rhumbline Advisers | 32,547 | $79.4K | 0.00% |
| Jump Financial, LLC | 21,099 | $51.5K | 0.00% |
| Corebridge Financial, Inc. | 16,401 | $40.2K | 0.00% |
| Point72 (DIFC) Ltd | 14,046 | $34.3K | 0.00% |
| Invesco Ltd. | 14,028 | $34.2K | 0.00% |
| Paloma Partners Management Co | 10,043 | $24.5K | 0.00% |
| Ameritas Investment Partners, Inc. | 2,987 | $7.29K | 0.00% |
| Legal & General Group Plc | 2,642 | $6.39K | 0.00% |
| California State Teachers Retirement System | 2,209 | $5.39K | 0.00% |
| TFC Financial Management | 1,500 | $3.66K | 0.00% |
| Amalgamated Bank | 1,055 | $3.00K | 0.00% |
| FMR LLC | 3 | $7 | 0.00% |
Sold out (12)
Institutions that held Werewolf Therapeutics, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.
| Institution | Shares, Q1 2024 | Value, Q1 2024 |
|---|---|---|
| Monashee Investment Management LLC | 890,000 | $5.77M |
| Laurion Capital Management LP | 201,236 | $1.30M |
| Susquehanna International Group, LLP | 175,798 | $1.14M |
| Denali Advisors LLC | 26,600 | $172.4K |
| ExodusPoint Capital Management, LP | 25,240 | $164.0K |
| Squarepoint Ops LLC | 24,594 | $159.4K |
| Raymond James Financial Services Advisors, Inc. | 23,659 | $153.3K |
| Point72 Asia (Singapore) Pte. Ltd. | 23,264 | $150.8K |
| Brevan Howard Capital Management LP | 18,910 | $122.5K |
| Y-Intercept (Hong Kong) Ltd | 14,154 | $91.7K |
| Omers Administration Corp | 10,800 | $70.0K |
| Macquarie Group Ltd | 940 | $6 |